Literature DB >> 18995830

FANCM and FAAP24 function in ATR-mediated checkpoint signaling independently of the Fanconi anemia core complex.

Spencer J Collis1, Alberto Ciccia, Andrew J Deans, Zuzana Horejsí, Julie S Martin, Sarah L Maslen, J Mark Skehel, Stephen J Elledge, Stephen C West, Simon J Boulton.   

Abstract

The Fanconi anemia (FA) pathway is implicated in DNA repair and cancer predisposition. Central to this pathway is the FA core complex, which is targeted to chromatin by FANCM and FAAP24 following replication stress. Here we show that FANCM and FAAP24 interact with the checkpoint protein HCLK2 independently of the FA core complex. In addition to defects in FA pathway activation, downregulation of FANCM or FAAP24 also compromises ATR/Chk1-mediated checkpoint signaling, leading to defective Chk1, p53, and FANCE phosphorylation; 53BP1 focus formation; and Cdc25A degradation. As a result, FANCM and FAAP24 deficiency results in increased endogenous DNA damage and a failure to efficiently invoke cell-cycle checkpoint responses. Moreover, we find that the DNA translocase activity of FANCM, which is dispensable for FA pathway activation, is required for its role in ATR/Chk1 signaling. Our data suggest that DNA damage recognition and remodeling activities of FANCM and FAAP24 cooperate with ATR/Chk1 to promote efficient activation of DNA damage checkpoints.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18995830     DOI: 10.1016/j.molcel.2008.10.014

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  109 in total

Review 1.  Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway.

Authors:  Hyungjin Kim; Alan D D'Andrea
Journal:  Genes Dev       Date:  2012-07-01       Impact factor: 11.361

Review 2.  Using synthetic DNA interstrand crosslinks to elucidate repair pathways and identify new therapeutic targets for cancer chemotherapy.

Authors:  Angelo Guainazzi; Orlando D Schärer
Journal:  Cell Mol Life Sci       Date:  2010-08-21       Impact factor: 9.261

3.  High levels of RAD51 perturb DNA replication elongation and cause unscheduled origin firing due to impaired CHK1 activation.

Authors:  Ann Christin Parplys; Jasna Irena Seelbach; Saskia Becker; Matthias Behr; Agnieszka Wrona; Camilla Jend; Wael Yassin Mansour; Simon Andreas Joosse; Horst-Werner Stuerzbecher; Helmut Pospiech; Cordula Petersen; Ekkehard Dikomey; Kerstin Borgmann
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  DNA crosslinking damage and cancer - a tale of friend and foe.

Authors:  Yaling Huang; Lei Li
Journal:  Transl Cancer Res       Date:  2013-06       Impact factor: 1.241

5.  Regulated degradation of FANCM in the Fanconi anemia pathway during mitosis.

Authors:  Younghoon Kee; Jung Min Kim; Alan D D'Andrea; Alan D'Andrea
Journal:  Genes Dev       Date:  2009-03-01       Impact factor: 11.361

6.  FANCM: fork pause, rewind and play.

Authors:  Spencer J Collis; Simon J Boulton
Journal:  EMBO J       Date:  2010-02-17       Impact factor: 11.598

7.  Structure analysis of FAAP24 reveals single-stranded DNA-binding activity and domain functions in DNA damage response.

Authors:  Yucai Wang; Xiao Han; Fangming Wu; Justin W Leung; Megan G Lowery; Huong Do; Junjie Chen; Chaowei Shi; Changlin Tian; Lei Li; Weimin Gong
Journal:  Cell Res       Date:  2013-09-03       Impact factor: 25.617

8.  The DNA translocase FANCM/MHF promotes replication traverse of DNA interstrand crosslinks.

Authors:  Jing Huang; Shuo Liu; Marina A Bellani; Arun Kalliat Thazhathveetil; Chen Ling; Johan P de Winter; Yinsheng Wang; Weidong Wang; Michael M Seidman
Journal:  Mol Cell       Date:  2013-10-24       Impact factor: 17.970

Review 9.  Fanconi anemia and the underlying causes of genomic instability.

Authors:  Julie Rageul; Hyungjin Kim
Journal:  Environ Mol Mutagen       Date:  2020-02-06       Impact factor: 3.216

10.  FANCM regulates DNA chain elongation and is stabilized by S-phase checkpoint signalling.

Authors:  Sarah Luke-Glaser; Brian Luke; Simona Grossi; Angelos Constantinou
Journal:  EMBO J       Date:  2009-12-10       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.